growth/size/body
• mice weight about 20% less than controls at 1 month of age, however as mice mature, they weight about 10% less at 3 months of age
|
skeleton
• 25% increase in the fraction of B220-CD3-CD11b-/lo, CD115 (c-Fms)high CD117 (c-Kit)high cells in the bone marrow, indicating an increase in the pre-osteoclast cell pool
|
• osteoclast differentiation and bone resorption in response to receptor activator of nuclear factor kappaB ligand in vitro are increased
|
• increase in endocortical osteoclast number and eroded surface in 1 month old mice, however this increase is no longer significant at 3 months of age
• however, no change in osteoblast number/perimeter, osteoblast surface, bone formation rate, or osteocyte number/bone area, indicating enhanced bone resorption without a coupled bone-forming response
• osteoblast, osteoclast, and osteocyte numbers are normal in 3 month old mice
|
short femur
(
J:230045
)
• femoral length is 12% shorter at 1 month of age, but at 3 months of age, femoral length in males is no different from controls and is only 5% shorter in females
|
• osteopenia affecting both cancellous and cortical bone
• osteopenia is less pronounced in females than males at 1 month of age but as females mature, osteopenia becomes more evident
|
• decrease in bone volume/tissue volume is secondary to a decrease in trabecular number
|
• 50% and 20% decrease in trabecular bone volume at 1 month of age in males and females, respectively
• non-significant decrease in cancellous bone volume of 30% in males and a significant decrease of 50% in females at 3 months of age
|
• cortical bone is porous
• decrease in cortical bone and overall bone size is more pronounced at 1 month of age than 3 months of age, although cortical bone architecture remains affected at 3 months
|
• at 3 months of age, osteoblast numbers and mineral apposition rates are increased in males, but not females
|
• decrease in cancellous bone volume in males is associated with decreased connectivity
|
• at 3 months of age, osteoblast numbers and mineral apposition rates are increased in males, but not females
|
• enhanced bone resorption without a coupled bone-forming response at 1 month of age
|
hematopoietic system
• 25% increase in the fraction of B220-CD3-CD11b-/lo, CD115 (c-Fms)high CD117 (c-Kit)high cells in the bone marrow, indicating an increase in the pre-osteoclast cell pool
|
• osteoclast differentiation and bone resorption in response to receptor activator of nuclear factor kappaB ligand in vitro are increased
|
• increase in endocortical osteoclast number and eroded surface in 1 month old mice, however this increase is no longer significant at 3 months of age
• however, no change in osteoblast number/perimeter, osteoblast surface, bone formation rate, or osteocyte number/bone area, indicating enhanced bone resorption without a coupled bone-forming response
• osteoblast, osteoclast, and osteocyte numbers are normal in 3 month old mice
|
immune system
• 25% increase in the fraction of B220-CD3-CD11b-/lo, CD115 (c-Fms)high CD117 (c-Kit)high cells in the bone marrow, indicating an increase in the pre-osteoclast cell pool
|
• osteoclast differentiation and bone resorption in response to receptor activator of nuclear factor kappaB ligand in vitro are increased
|
• increase in endocortical osteoclast number and eroded surface in 1 month old mice, however this increase is no longer significant at 3 months of age
• however, no change in osteoblast number/perimeter, osteoblast surface, bone formation rate, or osteocyte number/bone area, indicating enhanced bone resorption without a coupled bone-forming response
• osteoblast, osteoclast, and osteocyte numbers are normal in 3 month old mice
|
limbs/digits/tail
short femur
(
J:230045
)
• femoral length is 12% shorter at 1 month of age, but at 3 months of age, femoral length in males is no different from controls and is only 5% shorter in females
|
cellular
• osteoclast differentiation and bone resorption in response to receptor activator of nuclear factor kappaB ligand in vitro are increased
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Hajdu-Cheney syndrome | DOID:2736 |
OMIM:102500 |
J:230045 |